Interactions among thyroid function, insulin sensitivity, and serum lipid concentrations: The Fremantle diabetes study

被引:132
作者
Chubb, SAP
Davis, WA
Davis, TME
机构
[1] Fremantle Hosp, Dept Biochem, Fremantle, WA 6959, Australia
[2] Univ Western Australia, Fremantle Hosp, Sch Med & Pharmacol, Fremantle, WA 6959, Australia
关键词
D O I
10.1210/jc.2005-0298
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Context: Recent observations in healthy subjects showed that insulin resistance modifies the relationship between serum cholesterol and thyroid function. Objective: The aim of the study was to determine whether insulin sensitivity modifies the association between thyroid dysfunction and lipid parameters in diabetic patients. Design: This is a cross-sectional study. Setting: This is a community-based observational study. Patients: One hundred seventeen females with type 2 diabetes who were not taking oral hypoglycemic therapy, insulin, or lipid-lowering therapy participated in the study. Intervention: Serum TSH, insulin, total and high-density lipoprotein cholesterol, and triglycerides were measured. Main Outcome Measures: Age-adjusted multiple linear regression analysis of serum lipid concentrations and derived parameters, as functions of serum TSH and homeostasis model assessment-derived insulin sensitivity (HOMA-S), were measured. Results: The relationship among serum lipid concentrations, serum TSH, and HOMA-S was significantly modified by an interaction term ln(TSH)*ln(HOMA-S). In three-dimensional graphs, there were strong positive associations between TSH and lipid parameters with adverse cardiac risks at low insulin sensitivity that were absent at higher insulin sensitivity. The effect was strongest for lipid risk factors associated with insulin resistance. Conclusions: The interaction between thyroid function and insulin sensitivity is an important contributor to diabetic dyslipidemia and may justify T-4 replacement in some patients.
引用
收藏
页码:5317 / 5320
页数:4
相关论文
共 16 条
[1]
The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects [J].
Bakker, SJL ;
ter Maaten, JC ;
Popp-Snijders, C ;
Slaets, JPJ ;
Heine, RJ ;
Gans, ROB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) :1206-1211
[2]
The Colorado thyroid disease prevalence study [J].
Canaris, GJ ;
Manowitz, NR ;
Mayor, G ;
Ridgway, EC .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (04) :526-534
[3]
Lipoprotein profile in subclinical hypothyroidism: Response to Levothyroxine replacement, a randomized placebo-controlled study [J].
Caraccio, N ;
Ferrannini, E ;
Monzani, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (04) :1533-1538
[4]
Prevalence and progression of subclinical hypothyroidism in women with type 2 diabetes: the Fremantle Diabetes Study [J].
Chubb, SAP ;
Davis, WA ;
Inman, Z ;
Davis, TME .
CLINICAL ENDOCRINOLOGY, 2005, 62 (04) :480-486
[5]
Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: A quantitative review of the literature [J].
Danese, ND ;
Ladenson, PW ;
Meinert, CL ;
Powe, NR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (09) :2993-3001
[6]
Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: the Fremantle Diabetes Study [J].
Davis, TME ;
Zimmet, P ;
Davis, WA ;
Bruce, DG ;
Fida, S ;
Mackay, IR .
DIABETIC MEDICINE, 2000, 17 (09) :667-674
[7]
THE RELATIONSHIP BETWEEN SERUM-CHOLESTEROL AND SERUM THYROTROPIN, THYROXINE AND TRI-IODOTHYRONINE CONCENTRATIONS IN SUSPECTED HYPOTHYROIDISM [J].
ELDER, J ;
MCLELLAND, A ;
OREILLY, DS ;
PACKARD, CJ ;
SERIES, JJ ;
SHEPHERD, J .
ANNALS OF CLINICAL BIOCHEMISTRY, 1990, 27 :110-113
[8]
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[9]
Consensus statement: Subclinical thyroid dysfunction: A joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society [J].
Gharib, H ;
Tuttle, RM ;
Baskin, HJ ;
Fish, LH ;
Singer, PA ;
McDermott, MT .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (01) :581-585
[10]
Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes [J].
Jiang, R ;
Schulze, MB ;
Li, TC ;
Rifal, N ;
Stampfer, MJ ;
Rimm, EB ;
Hu, FB .
DIABETES CARE, 2004, 27 (08) :1991-1997